Use of Apheretic Technologies in Cardiovascular Disease

University of Pavia

Status: Withdrawn

Conditions: Dyslipidemia

Treatments: Procedure: H.E.L.P. apheresis

Study type: Interventional

Funder types: Other

Identifiers

NCT02380534

P-20140023880

Details and patient eligibility

About

To evaluate the effects of H.E.L.P. apheresis on lipid profile, Lp(a) level, and some inflammatory adypocytokines in patients with high cardiovascular risk.

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• high Lp(a) not responsive to diet and pharmacological treatment

Exclusion criteria

• heart failure
• hepatic failure
• renal failure

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

active procedure

Experimental group

Description:

High cardiovascular risk patients will undergo H.E.L.P. apheresis.

Treatment:

Procedure: H.E.L.P. apheresis